Evidence map›Paper›PMID 28487369›Full record

ArticleThe Journal of biological chemistry2017

Takazumi Taniguchi, Ashley M Woodward, Paula Magnelli, Nicole M McColgan, Sylvain Lehoux, Sarah Melissa P Jacobo, Jérôme Mauris, Pablo Argüeso

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Ocular Surface Microbiota Alterations Following FS-LASIK and Their Association With Postoperative Dry Eye.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Ocular surface glycocalyx in health and disease.Frontiers in cell and developmental biology · 2025
    Review
  9. Article
  10. Article
  11. Eliminative Oximation of O-Glycans from Mucins.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  12. Mucin Glycans: A Target for Cancer Therapy.Molecules (Basel, Switzerland) · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Takazumi TaniguchiFrom the Schepens Eye Research Institute and Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114.
Ashley M WoodwardFrom the Schepens Eye Research Institute and Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114.
Paula MagnelliNew England Biolabs, Ipswich, Massachusetts 01938, and.
Nicole M McColganFrom the Schepens Eye Research Institute and Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114.
Sylvain Lehouxthe Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215.
Sarah Melissa P JacoboFrom the Schepens Eye Research Institute and Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114.
Jérôme MaurisFrom the Schepens Eye Research Institute and Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114.
Pablo ArgüesoFrom the Schepens Eye Research Institute and Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114, pablo_argueso@meei.harvard.edu.
Harvard University · USMassachusetts Eye and Ear Infirmary · USBeth Israel Deaconess Medical Center · USNew England Biolabs (United States) · USSmith-Kettlewell Eye Research Institute · US

Funding

VISION RESEARCHP30EY003790 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Patricia Ann D'Amore · 1985 to 2026
$25.5M
Overall Priority Score P41GM103694 · NIGMS · EMORY UNIVERSITY · PI CUMMINGS, RICHARD D · 2013 to 2018
$6.9M
N-Glycosylation and Ocular Surface HomeostasisR01EY026147 · NEI · TUFTS MEDICAL CENTER · PI Pablo Argueso · 2016 to 2026
$5.1M
O-Glycans on Mucins at the Ocular SurfaceR01EY014847 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI ARGUESO, PABLO · 2003 to 2014
$4.0M
NEI NIH HHS P30 EY003790NEI NIH HHS R01 EY014847NEI NIH HHS R01 EY026147NIGMS NIH HHS P41 GM103694
6 · The paper itself

Abstract

Transmembrane mucins are highly

Indexed as

Blood ProteinsCA-125 AntigenCell Line, TransformedCorneaEpithelial CellsGalectin 3GalectinsGlycocalyxGlycosylationHumansMembrane ProteinsProtein StabilityBlood ProteinsCA-125 AntigenGalectin 3GalectinsLGALS3 protein, humanMembrane ProteinsMUC16 protein, humanepithelial cellgalectinglycosyltransferasemucinN-linked glycosylation

Identifiers

PMID28487369
PMCPMC5491790
OpenAlexW2612203522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.